Results of international trial show promise in rare, difficult to treat cancer: results from the RADIANT-4 trial
Results of international trial show promise in rare, difficult to treat cancer: results from the RADIANT-4 trial Neuroendocrine tumours (NETs) develop in the neuroendocrine system, responsible for producing the hormones that regulate the working of different organs in the body. They are rare, incurable, and treatments for them are limited...
Read MoreLung cancer survival rates improve with CT scan follow-up
Patients with recurrent lung cancer have better post-surgery survival rates if their management includes a follow-up programme based on computer tomography (CT) of the chest, according to new findings. The findings, presented at the ERS International Congress 2015 in Amsterdam today (27 September, 2015), is the first to show improved...
Read More
